PEPTIDES FOR WEIGHT LOSS
RESEARCH REFERENCE · INCRETIN AXIS · GLP-1 · GIP · GLUCAGON
Eight research peptides studied for body composition and glycemic control. The largest weight-loss effects in published trials come from the incretin axis: GLP-1 receptor (the long-acting GLP-1 agonist, the daily GLP-1 agonist), dual GLP-1 plus GIP (the GLP-1 / GIP dual agonist), triple GLP-1 plus GIP plus glucagon (the triple-receptor incretin agonist, the GLP-1 / glucagon dual agonist), and amylin-receptor co-agonists (the amylin receptor agonist). MOTS-c sits outside the incretin family · a mitochondrial-derived peptide studied for metabolic effects. AOD-9604 is a synthetic C-terminal fragment of human growth hormone studied for lipolytic activity.
WHAT THE RESEARCH SHOWS
Incretin receptor agonism drives glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying, and central appetite suppression. Adding the GIP arm (the GLP-1 / GIP dual agonist, the triple-receptor incretin agonist) increases absolute weight loss versus single-agonist GLP-1 compounds. Adding the glucagon arm (the triple-receptor incretin agonist, the GLP-1 / glucagon dual agonist, the GLP-1 / glucagon dual agonist (β)) further increases energy expenditure via thermogenic signaling, which is the leading hypothesis for why the triple-receptor incretin agonist Phase 2 produced deeper body-weight reductions than dual-agonist trials at comparable timepoints.
COMPOUND CLUSTER · 8 ENTRIES





.png)


RECEPTOR AGONISM MATRIX
FAQ
▶ What peptide has the most weight loss in clinical trials?
the triple-receptor incretin agonist leads published trial data. The Phase 2 NEJM trial (Jastreboff 2023, PMID 37366315) reported -24.2% LS mean body weight at the 12 mg dose arm at 48 weeks. the GLP-1 / GIP dual agonist at 15 mg in SURMOUNT-1 reached -22.5% at 72 weeks. the long-acting GLP-1 agonist 2.4 mg in STEP-1 reached -14.9% at 68 weeks. the triple-receptor incretin agonist is investigational. the GLP-1 / GIP dual agonist is FDA-approved as separate FDA-approved class members. the long-acting GLP-1 agonist is FDA-approved as an FDA-approved class member.
▶ Are research peptides for weight loss FDA approved?
Some incretin agonists are FDA approved as prescription drugs. the GLP-1 / GIP dual agonist (separate FDA-approved class members), the long-acting GLP-1 agonist (separate FDA-approved class members), and the daily GLP-1 agonist (the FDA-approved class member) are FDA approved. the triple-receptor incretin agonist, the GLP-1 / glucagon dual agonist, the oral GLP-1 receptor mimetic, the GLP-1 / glucagon dual agonist (β) and the amylin receptor agonist are investigational. Research-grade material sold as a reference compound is for in-vitro laboratory use only, distinct from any branded prescription product.
▶ the triple-receptor incretin agonist vs the GLP-1 / GIP dual agonist for weight loss?
the triple-receptor incretin agonist is a triple GLP-1 plus GIP plus glucagon agonist. the GLP-1 / GIP dual agonist is a dual GLP-1 plus GIP agonist. The added glucagon arm in the triple-receptor incretin agonist drives a thermogenic / energy-expenditure component on top of the appetite and insulin effects. Phase 2 the triple-receptor incretin agonist produced -24.2% body-weight reduction at 48 weeks vs the GLP-1 / GIP dual agonist -22.5% at 72 weeks. See the full /vs/the triple-receptor incretin agonist-vs-the GLP-1 / GIP dual agonist comparison.
▶ How are these used in research?
All compounds on this page are supplied as research-grade chemical reference material for in-vitro laboratory studies. Each compound page documents the published trial dosing schedule, half-life, mechanism, and per-receptor pharmacology. GigaResearch does not recommend any human dose. For purchase of research-grade material see gigacompounds.com.
RELATED
- the triple-receptor incretin agonist vs the GLP-1 / GIP dual agonist · Head to Head
- Body Composition Research
- Glycemic Control Research
- Incretin Axis Mechanism
- Peptide Half-Life Chart
SOURCED FROM GIGACOMPOUNDS
Research-grade reference compounds available at GigaCompounds · ≥99% purity · per-batch CoA. For laboratory research use only.